MTH-3 sensitizes oral cancer cells to cisplatin via regulating TFEB.
Shih-Chang TsaiJai-Sing YangChi-Cheng LuFuu-Jen TsaiYu-Jen ChiuSheng-Chu KuoPublished in: The Journal of pharmacy and pharmacology (2022)
MTH-3 induces autophagy and apoptosis of CAR cells via TFEB. MTH-3 might be an effective pharmacological agent for treating oral cancer cells.